Elevance Health (ELV) Profit After Tax (2009 - 2026)

Elevance Health (ELV) has reported Profit After Tax for 18 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Profit After Tax fell 16.58% year-over-year to $1.5 billion; the TTM figure through Jun 2026 stood at $4.9 billion (down 7.6% YoY), while the FY2025 annual figure was $5.7 billion, down 5.19% from the prior year.
• Profit After Tax fell to $1.5 billion in Q2 2026 per ELV's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Profit After Tax topped out at $2.3 billion in Q2 2024 and bottomed at $413.0 million in Q4 2024.
• Historically, Profit After Tax has averaged $1.5 billion across 5 years, with a median of $1.6 billion in 2022.
• Annual changes were most pronounced in 2024 — Profit After Tax slumped 51.75% — and 2025, when it surged 32.2%.
• Elevance Health's Profit After Tax stood at $865.0 million in 2022, then retreated by 1.04% to $856.0 million in 2023, then plunged by 51.75% to $413.0 million in 2024, then soared by 32.2% to $546.0 million in 2025, then jumped by 166.3% to $1.5 billion in 2026.
• Business Quant data shows ELV's Profit After Tax at $1.5 billion in Q2 2026, $1.8 billion in Q1 2026, and $546.0 million in Q4 2025.